Recent Work for Catherine Dowling
PrioThera Series B Investment
03/FEB/2026Byrne Wallace Shields LLP is pleased to have acted for our client, biotech company, PrioThera in rel..
Neuromod Devices Limited
13/APR/2023Byrne Wallace Shields LLP advises Neuromod Devices Limited...
Azets Ireland
09/MAR/2023Byrne Wallace Shields LLP advises the partners in accountancy and business advisory firm Baker Tilly..
